MitrAssist has developed an approach to treating patients with life-threatening mitral regurgitation (MR) that involves neither repair nor replacement. Instead, the companys proprietary valve implant is placed on top of the natural valve to work in unison with it and to enhance valve functionality.
MitrAssists valve-in-valve approach overcomes the various challenges of MR and offers an alternative treatment solution for all MR patients. Made from biomedical and biological materials, MitrAssists valve offers improved biocompatibility and patient recovery time.
Cumulative Funding Raised Over Time ($)
Employees Over Time
MitrAssist Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Sep 27, 2023
www.dealstreetasia.com
Centurium, 6 Dimensions lead $100m Series C round for medtech startup MitrAssist
#Investment #Expand
Sep 27, 2023
g-medtech.com
Shanghai MITRASSIST Medical Closes Nearly $100 Million Series C Financing - G-MedTech News Center
#Investment #Expand
Dec 2, 2020
en.globes.co.il
Israeli medical valve co MitrAssist raises $50m
#Investment #Expand
Nov 9, 2017
nocamels.com
Heart Valve Company MitrAssist Raises $30M
#Investment
Nov 8, 2017
www.calcalistech.com
Fosun Leads $30 Million Round for Heart Valve Company MitrAssist